表紙
市場調查報告書

全球食管運動障礙治療市場:GERD和肥胖症的患病率上升

Global Market Study on Ineffective Esophageal Motility Treatment: Increasing Prevalence of GERD and Obesity to Propel Market Growth

出版商 Persistence Market Research 商品編碼 952528
出版日期 內容資訊 英文 302 Pages
商品交期: 2-3個工作天內
價格
全球食管運動障礙治療市場:GERD和肥胖症的患病率上升 Global Market Study on Ineffective Esophageal Motility Treatment: Increasing Prevalence of GERD and Obesity to Propel Market Growth
出版日期: 2020年06月24日內容資訊: 英文 302 Pages
簡介

本報告重點關注影響市場增長和市場主要運動的動力,並且還調查了全球食道運動障礙治療市場,重點關注宏觀經濟和微觀經濟因素。提供有關市場趨勢和需求,指示,最終用戶,地理分析和預測,市場結構分析以及競爭性分析的信息。

目錄

第1章執行摘要

第2章市場概述

  • 調查目標/分類
  • 市場定義/範圍/限制

第3章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品發展趨勢

第4章市場背景

  • 宏觀經濟因素
    • 全球GDP增長前景
    • 全球醫療保健行業前景
    • 人均醫療支出展望
  • 預測變量:相關性和影響
    • 生活方式改變和肥胖增加
    • 藥物開發的技術進步
    • 最新產品發佈
    • 增加食道運動障礙的發生率
  • 市場動態
    • 促進增長的因素
    • 生長抑製劑
    • 市場機會
  • 價值鏈分析

第5章市場情況

  • 產品採用/使用情況分析
  • 疾病流行病學
  • 監管方案
  • 兌換方案
  • 各公司的主要戰略

第6章世界市場價格分析

  • 區域價格分析
  • 平均價格分析基準

第7章全球市場需求分析和預測

  • 過去的市場分析
  • 當前和未來市場預測
    • 同比增長趨勢分析

第8章按產品進行的市場分析和預測

  • 簡介/主要發現
  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 設備
    • 製藥
  • 市場吸引力分析

第9章按指標進行市場分析和預測

  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 吞嚥困難
    • 反流性食管炎
    • 胸痛
    • Acarasia
  • 市場吸引力分析

第10章市場分析和預測:最終用戶

  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 醫療機構的銷售
    • 零售
  • 市場吸引力分析

第11章按地區進行市場分析和預測

  • 簡介
  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東/非洲
  • 市場吸引力分析

第12章北美市場分析和預測

  • 簡介
  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 按國家
    • 按產品
    • 按指示
    • 按最終用戶
  • 市場吸引力分析
  • 增長因素與約束影響分析

第13章拉丁美洲市場分析和預測

  • 簡介
  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 按國家
    • 產品
    • 按指示
    • 按最終用戶
  • 市場吸引力分析
  • 增長因素與約束影響分析

第14章歐洲市場分析和預測

  • 簡介
  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 按國家
    • 產品
    • 按指示
    • 按最終用戶
  • 市場吸引力分析
  • 增長因素與約束影響分析

第15章南亞市場分析和預測

  • 簡介
  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 按國家
    • 產品
    • 按指示
    • 按最終用戶
  • 市場吸引力分析
  • 增長因素與約束影響分析

第16章東亞市場分析和預測

  • 簡介
  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 按國家
    • 產品
    • 按指示
    • 按最終用戶
  • 市場吸引力分析
  • 增長因素與約束影響分析

第17章大洋洲市場分析和預測

  • 簡介
  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 按國家
    • 產品
    • 按指示
    • 按最終用戶
  • 市場吸引力分析
  • 增長因素與約束影響分析

第18章中東和非洲市場分析和預測

  • 簡介
  • 過去的表現分析
  • 當前和將來的市場分析和預測
    • 按國家
    • 產品
    • 按指示
    • 按最終用戶
  • 市場吸引力分析
  • 增長因素與約束影響分析

第19章主要國家和新興市場的市場分析和預測

  • 簡介
    • 過去的表現分析
    • 當前和將來的市場分析和預測
  • 新興市場分析
    • 中國
    • 印度
    • 巴西
  • 美國
  • 加拿大
  • 墨西哥
  • 英國
  • 德國
  • 法國
  • 意大利
  • 西班牙
  • 荷比盧三國
  • 俄羅斯
  • 日本
  • 韓國
  • 澳大利亞
  • 海灣合作委員會國家
  • 南非

第20章市場結構分析

  • 市場結構分析:按公司層次劃分
  • 主要公司的市場佔有率分析
  • 市場佔有率分析
    • 每個公司的區域足跡

第21章競爭分析

  • 競爭性儀表板
  • 競爭基準
  • 競爭分析
    • Johnson & Johnson
    • Mylan Pharmaceutical
    • MediGus Ltd.
    • Torax Medical
    • Medtronic plc.
    • AstraZeneca plc.
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • GlaxoSmithKline plc.
    • Bayer AG
    • Pfizer Inc.
    • Bausch Health Companies Inc.
    • LABORIE
    • Mederi Therapeutics, Inc.
    • Becton, Dickinson and Company (C. R. Bard, Inc.)
    • EndoGastric Solutions, Inc
    • Olympus
    • Pentax

第22章調查假設和首字母縮寫詞

第23章調查方法

目錄

Scope of the Report

The latest publication by Persistence Market Research (PMR) on the global ineffective esophageal motility treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global ineffective esophageal motility treatment market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the ineffective esophageal motility treatment market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for the successful growth of the ineffective esophageal motility treatment market are presented in this comprehensive report, including year-on-year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR's research. This research study can support readers to know the demand for ineffective esophageal motility treatment and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the ineffective esophageal motility treatment market, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the ineffective esophageal motility treatment market. The insights and wisdom presented in PMR's study can be leveraged by shareholders in the ineffective esophageal motility treatment market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to macro- as well as micro-economic variables affecting the business scenario in the Ineffective esophageal motility treatment market are also included in the current study. Depending on potential developments in the ineffective esophageal motility treatment market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this ineffective esophageal motility treatment market report, minor companies and new entrants can make suitable company choices to achieve traction in the ineffective esophageal motility treatment market.

Key Questions Answered:

  • Which regions will continue to remain the most profitable regional markets for ineffective esophageal motility treatment market players?
  • Which factors will induce a change in the demand for ineffective esophageal motility treatment during the assessment period?
  • How will changing trends impact the ineffective esophageal motility treatment market?
  • How can market players capture the low-hanging opportunities in the ineffective esophageal motility treatment in developed regions?
  • What are the winning strategies of stakeholders in the ineffective esophageal motility treatment market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the ineffective esophageal motility treatment market?
  • What are the developmental trends in ineffective esophageal motility treatment sectors that will impact the market?
  • How can businesses in the ineffective esophageal motility treatment market avail the growth opportunities in developed and emerging sectors?

Research Methodology:

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the ineffective esophageal motility treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the ineffective esophageal motility treatment market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the ineffective esophageal motility treatment market, and makes PMR's projections on the growth prospects of the ineffective esophageal motility treatment market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Trends
  • 1.3. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Development Trends

4. Market Background

  • 4.1. Macro-Economic Factors
    • 4.1.1. Global GDP Growth Outlook
    • 4.1.2. Global Healthcare Outlook
    • 4.1.3. Per Capita Healthcare Expenditure Outlook
  • 4.2. Forecast Factors - Relevance & Impact
    • 4.2.1. Change in Lifestyle & Growing Obesity Rate
    • 4.2.2. Technological Advancements in Drug Development
    • 4.2.3. Recent Product Launches
    • 4.2.4. Increasing Incidence of Ineffective Esophageal Motility
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunity Analysis
  • 4.4. Value Chain Analysis

5. Market Context

  • 5.1. Product Adoption / Usage Analysis
  • 5.2. Disease Epidemiology
  • 5.3. Regulatory Scenario
  • 5.4. Reimbursement Scenario
  • 5.5. Key Strategies Followed By Manufacturers

6. Global Ineffective Esophageal Motility Treatment Market - Pricing Analysis

  • 6.1. Regional Pricing Analysis Product
  • 6.2. Global Average Pricing Analysis Benchmark

7. Global Ineffective Esophageal Motility Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) & Volume Units Analysis Product, 2015 - 2019
  • 8.3. Current and Future Market Size (US$ Mn) & Volume Units Analysis and Forecast Product, 2020 - 2030
    • 8.3.1. Devices
      • 8.3.1.1. Reflux Management Systems
      • 8.3.1.2. Endoscopic Pain Modulators
      • 8.3.1.3. Endostaplers
      • 8.3.1.4. Radiofrequency (RF) Ablation Devices
      • 8.3.1.5. Myotomy Devices
    • 8.3.2. Drugs
      • 8.3.2.1. H2 Receptor Antagonist
      • 8.3.2.2. Antacids
      • 8.3.2.3. Proton Pump Inhibitors
      • 8.3.2.4. Dopamine Antagonist
      • 8.3.2.5. Prokinetic Agents
      • 8.3.2.6. Calcium Channel Blockers
  • 8.4. Market Attractiveness Analysis Product

9. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, By Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015 - 2019
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020 - 2030
    • 9.3.1. Dysphagia
    • 9.3.2. GERD
    • 9.3.3. Burning chest pain
    • 9.3.4. Achalasia
  • 9.4. Market Attractiveness Analysis By Indication

10. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015 - 2019
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020 - 2030
    • 10.3.1. Institutional sales
      • 10.3.1.1. Hospitals
      • 10.3.1.2. Ambulatory Surgical Centers
    • 10.3.2. Retail Sales
      • 10.3.2.1. Retail Pharmacies
      • 10.3.2.2. Drug Stores
      • 10.3.2.3. Mail order Pharmacies
  • 10.4. Market Attractiveness Analysis By End User

11. Global Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. Product
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Drivers and Restraints - Impact Analysis

13. Latin America Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Rest of Latin America
    • 13.3.2. Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Drivers and Restraints - Impact Analysis

14. Europe Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Drivers and Restraints - Impact Analysis

15. South Asia Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Drivers and Restraints - Impact Analysis

16. East Asia Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Drivers and Restraints - Impact Analysis

17. Oceania Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Northern Africa
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East and Africa
    • 18.3.2. Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Ineffective Esophageal Motility Treatment Market Analysis 2015-2019 and Forecast 2020-2030

  • 19.1. Introduction
    • 19.1.1. Market Value Proportion Analysis, By Key Countries
    • 19.1.2. Global Vs. Country Growth Comparison
  • 19.2. Emerging Countries Ineffective Esophageal Motility Treatment Market Analysis
    • 19.2.1. China
    • 19.2.2. India
    • 19.2.3. Brazil
  • 19.3. U.S. Ineffective Esophageal Motility Treatment Market Analysis
    • 19.3.1. By Product
    • 19.3.2. By Indication
    • 19.3.3. By End User
  • 19.4. Canada Ineffective Esophageal Motility Treatment Market Analysis
    • 19.4.1. By Product
    • 19.4.2. By Indication
    • 19.4.3. By End User
  • 19.5. Mexico Ineffective Esophageal Motility Treatment Market Analysis
    • 19.5.1. By Product
    • 19.5.2. By Indication
    • 19.5.3. By End User
  • 19.6. U.K. Ineffective Esophageal Motility Treatment Market Analysis
    • 19.6.1. By Product
    • 19.6.2. By Indication
    • 19.6.3. By End User
  • 19.7. Germany Ineffective Esophageal Motility Treatment Market Analysis
    • 19.7.1. By Product
    • 19.7.2. By Indication
    • 19.7.3. By End User
  • 19.8. France Ineffective Esophageal Motility Treatment Market Analysis
    • 19.8.1. By Product
    • 19.8.2. By Indication
    • 19.8.3. By End User
  • 19.9. Italy Ineffective Esophageal Motility Treatment Market Analysis
    • 19.9.1. By Product
    • 19.9.2. By Indication
    • 19.9.3. By End User
  • 19.10. Spain Ineffective Esophageal Motility Treatment Market Analysis
    • 19.10.1. By Product
    • 19.10.2. By Indication
    • 19.10.3. By End User
  • 19.11. BENELUX Ineffective Esophageal Motility Treatment Market Analysis
    • 19.11.1. By Product
    • 19.11.2. By Indication
    • 19.11.3. By End User
  • 19.12. Russia Ineffective Esophageal Motility Treatment Market Analysis
    • 19.12.1. By Product
    • 19.12.2. By Indication
    • 19.12.3. By End User
  • 19.13. Japan Ineffective Esophageal Motility Treatment Market Analysis
    • 19.13.1. By Product
    • 19.13.2. By Indication
    • 19.13.3. By End User
  • 19.14. South Korea Ineffective Esophageal Motility Treatment Market Analysis
    • 19.14.1. By Product
    • 19.14.2. By Indication
    • 19.14.3. By End User
  • 19.15. Australia Ineffective Esophageal Motility Treatment Market Analysis
    • 19.15.1. By Product
    • 19.15.2. By Indication
    • 19.15.3. By End User
  • 19.16. GCC Countries Ineffective Esophageal Motility Treatment Market Analysis
    • 19.16.1. By Product
    • 19.16.2. By Indication
    • 19.16.3. By End User
  • 19.17. South Africa Ineffective Esophageal Motility Treatment Market Analysis
    • 19.17.1. By Product
    • 19.17.2. By Indication
    • 19.17.3. By End User

20. Market Structure Analysis

  • 20.1. Market Structure Analysis by Tier of Companies
  • 20.2. Market Share Analysis for Top Players
  • 20.3. Market Presence Analysis
    • 20.3.1. By Regional footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Johnson & Johnson
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.1.4. Sales Footprint
      • 21.3.1.5. Strategy Overview
    • 21.3.2. Mylan Pharmaceutical
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.2.4. Sales Footprint
      • 21.3.2.5. Strategy Overview
    • 21.3.3. MediGus Ltd.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.3.4. Sales Footprint
      • 21.3.3.5. Strategy Overview
    • 21.3.4. Torax Medical
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.4.4. Sales Footprint
      • 21.3.4.5. Strategy Overview
    • 21.3.5. Medtronic plc.
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.5.4. Sales Footprint
      • 21.3.5.5. Strategy Overview
    • 21.3.6. AstraZeneca plc.
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.6.4. Sales Footprint
      • 21.3.6.5. Strategy Overview
    • 21.3.7. Teva Pharmaceutical Industries Ltd.
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.7.4. Sales Footprint
      • 21.3.7.5. Strategy Overview
    • 21.3.8. Takeda Pharmaceutical Company Limited
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.8.4. Sales Footprint
      • 21.3.8.5. Strategy Overview
    • 21.3.9. GlaxoSmithKline plc.
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.9.4. Sales Footprint
      • 21.3.9.5. Strategy Overview
    • 21.3.10. Bayer AG
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.10.4. Sales Footprint
      • 21.3.10.5. Strategy Overview
    • 21.3.11. Pfizer Inc.
      • 21.3.11.1. Overview
      • 21.3.11.2. Product Portfolio
      • 21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.11.4. Sales Footprint
      • 21.3.11.5. Strategy Overview
    • 21.3.12. Bausch Health Companies Inc.
      • 21.3.12.1. Overview
      • 21.3.12.2. Product Portfolio
      • 21.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.12.4. Sales Footprint
      • 21.3.12.5. Strategy Overview
    • 21.3.13. LABORIE
      • 21.3.13.1. Overview
      • 21.3.13.2. Product Portfolio
      • 21.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.13.4. Sales Footprint
      • 21.3.13.5. Strategy Overview
    • 21.3.14. Mederi Therapeutics, Inc.
      • 21.3.14.1. Overview
      • 21.3.14.2. Product Portfolio
      • 21.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.14.4. Sales Footprint
      • 21.3.14.5. Strategy Overview
    • 21.3.15. Becton, Dickinson and Company (C. R. Bard, Inc.)
      • 21.3.15.1. Overview
      • 21.3.15.2. Product Portfolio
      • 21.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.15.4. Sales Footprint
      • 21.3.15.5. Strategy Overview
    • 21.3.16. EndoGastric Solutions, Inc
      • 21.3.16.1. Overview
      • 21.3.16.2. Product Portfolio
      • 21.3.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.16.4. Sales Footprint
      • 21.3.16.5. Strategy Overview
    • 21.3.17. Olympus
      • 21.3.17.1. Overview
      • 21.3.17.2. Product Portfolio
      • 21.3.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.17.4. Sales Footprint
      • 21.3.17.5. Strategy Overview
    • 21.3.18. Pentax
      • 21.3.18.1. Overview
      • 21.3.18.2. Product Portfolio
      • 21.3.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.18.4. Sales Footprint
      • 21.3.18.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

List of Tables:

  • Table 01: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 02: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 03: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 04: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 05: Global Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
  • Table 06: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 07: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 08: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 09: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 10: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 11: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 12: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 13: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 14: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 15: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 16: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 17: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 18: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 19: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 20: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 21: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 22: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 23: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 24: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 25: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 26: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 27: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 28: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 29: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 30: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 31: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 32: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 33: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 34: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 35: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 36: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 37: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 38: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 39: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 40: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 41: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 42: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 43: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 44: China Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 45: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 46: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 47: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 48: India Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 49: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 50: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 51: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
  • Table 52: Brazil Ineffective Esophageal Motility Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

List of Figures:

  • Figure 01: Global Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2019 (A)
  • Figure 02: Global Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2019 (A)
  • Figure 03: Global Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2019 (A)
  • Figure 04: Global Ineffective Esophageal Motility Treatment Market Value Share, By Region, 2019 (A)
  • Figure 05: Primary expected source of payment for visits at which Ineffective Esophageal Motility Treatment were prescribed, by age: United States, 2014-2016
  • Figure 06: Regional Average Pricing Analysis (US$) of Reflux Management Systems (2019A)
  • Figure 07: Regional Average Pricing Analysis (US$) of Endostapler (2019A)
  • Figure 08: Regional Average Pricing Analysis (US$) of Myotomy Devices (2019A)
  • Figure 09: Regional Average Pricing Analysis (US$) of Stretta System (2019A)
  • Figure 10: Global Ineffective Esophageal Motility Treatment Drugs Market Value Analysis and Forecast, 2020-2030 (US$ Mn)
  • Figure 11: Global Ineffective Esophageal Motility Treatment Drugs Market Absolute $ Opportunity (US$ Mn), 2015-2019
  • Figure 12: Global Ineffective Esophageal Motility Treatment Drugs Market Absolute $ Opportunity (US$ Mn), 2020-2030
  • Figure 13: Global Ineffective Esophageal Motility Treatment Market Share Analysis (%) By Product, 2020 & 2030
  • Figure 14: Global Ineffective Esophageal Motility Treatment Market Y-o-Y Growth (%) By Product, 2020-2030
  • Figure 15: Global Ineffective Esophageal Motility Treatment Market Attractiveness Analysis, By Product
  • Figure 16: Global Ineffective Esophageal Motility Treatment Market Share Analysis (%) By Indication, 2020 & 2030
  • Figure 17: Global Ineffective Esophageal Motility Treatment Market Y-o-Y Growth (%) By Indication, 2020-2030
  • Figure 18: Global Ineffective Esophageal Motility Treatment Market Attractiveness Analysis, By Indication
  • Figure 19: Global Ineffective Esophageal Motility Treatment Market Share Analysis (%) By End User, 2020 & 2030
  • Figure 20: Global Ineffective Esophageal Motility Treatment Market Y-o-Y Growth (%) By End User, 2020-2030
  • Figure 21: Global Ineffective Esophageal Motility Treatment Market Attractiveness Analysis, By End User
  • Figure 22: Global Ineffective Esophageal Motility Treatment Market Share Analysis (%) By Region, 2020 & 2030
  • Figure 23: Global Ineffective Esophageal Motility Treatment Market Y-o-Y Growth (%) By Region, 2020-2030
  • Figure 24: Global Ineffective Esophageal Motility Treatment Market Attractiveness Analysis, By Region
  • Figure 25: North America Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 26: North America Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 27: North America Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 28: North America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 29: North America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 30: North America Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 31: North America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 32: North America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 33: North America Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 34: North America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 35: North America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 36: North America Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 37: North America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 38: North America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 39: Latin America Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 40: Latin America Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 41: Latin America Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 42: Latin America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 43: Latin America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 44: Latin America Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 45: Latin America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 46: Latin America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 47: Latin America Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 48: Latin America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 49: Latin America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 50: Latin America Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 51: Latin America Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 52: Latin America Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 53: Europe Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 54: Europe Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 55: Europe Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 56: Europe Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 57: Europe Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 58: Europe Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 59: Europe Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 60: Europe Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 61: Europe Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 62: Europe Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 63: Europe Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 64: Europe Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 65: Europe Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 66: Europe Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 67: East Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 68: East Asia Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 69: East Asia Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 70: East Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 71: East Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 72: East Asia Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 73: East Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 74: East Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 75: East Asia Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 76: East Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 77: East Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 78: East Asia Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 79: East Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 80: East Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 81: South Asia Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 82: South Asia Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 83: South Asia Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 84: South Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 85: South Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 86: South Asia Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 87: South Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 88: South Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 89: South Asia Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 90: South Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 91: South Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 92: South Asia Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 93: South Asia Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 94: South Asia Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 95: Oceania Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 96: Oceania Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 97: Oceania Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 98: Oceania Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 99: Oceania Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 100: Oceania Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 101: Oceania Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 102: Oceania Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 103: Oceania Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 104: Oceania Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 105: Oceania Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 106: Oceania Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 107: Oceania Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 108: Oceania Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 109: MEA Ineffective Esophageal Motility Treatment Market Size (US$ Mn), 2015-2019
  • Figure 110: MEA Ineffective Esophageal Motility Treatment Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 111: MEA Ineffective Esophageal Motility Treatment Market Analysis by Country - 2020 & 2030
  • Figure 112: MEA Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 113: MEA Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Country, 2020-2030
  • Figure 114: MEA Ineffective Esophageal Motility Treatment Market Analysis by Product - 2020 & 2030
  • Figure 115: MEA Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Product, 2020-2030
  • Figure 116: MEA Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Product, 2020-2030
  • Figure 117: MEA Ineffective Esophageal Motility Treatment Market Analysis by Indication -2020 & 2030
  • Figure 118: MEA Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by Indication, 2020-2030
  • Figure 119: MEA Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 120: MEA Ineffective Esophageal Motility Treatment Market Analysis by End User -2020 & 2030
  • Figure 121: MEA Ineffective Esophageal Motility Treatment Market Y-o-Y Growth Projections by End User, 2020-2030
  • Figure 122: MEA Ineffective Esophageal Motility Treatment Market Attractiveness Analysis by End User, 2020-2030
  • Figure 123: US Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 124: US Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 125: US Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 126: Canada Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 127: Canada Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 128: Canada Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 129: Mexico Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 130: Mexico Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 131: Mexico Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 132: U.K. Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 133: U.K. Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 134: U.K. Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 135: Germany Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 136: Germany Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 137: Germany Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 138: France Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 139: France Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 140: France Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 141: Italy Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 142: Italy Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 143: Italy Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 144: Spain Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 145: Spain Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 146: Spain Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 147: BENELUX Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 148: BENELUX Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 149: BENELUX Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 150: Russia Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 151: Russia Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 152: Russia Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 153: Japan Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 154: Japan Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 155: Japan Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 156: South Korea Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 157: South Korea Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 158: South Korea Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 159: Australia Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 160: Australia Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 161: Australia Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 162: GCC Countries Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 163: GCC Countries Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 164: GCC Countries Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)
  • Figure 165: South Africa Ineffective Esophageal Motility Treatment Market Value Share, By Product, 2020 (E)
  • Figure 166: South Africa Ineffective Esophageal Motility Treatment Market Value Share, By Indication, 2020 (E)
  • Figure 167: South Africa Ineffective Esophageal Motility Treatment Market Value Share, By End User, 2020 (E)